by In2Pharma | May 4, 2021 | News
The Netherlands The Dutch Medicines Evaluation Board (MEB) published an update of the policy document (MEB 44) regarding Direct Healthcare Professional Communications (DHPCs). This policy presents a framework for the way in which the MEB deals with DHPCs and the...
